Accustem Sciences Inc.
OTC · CIK 0001850767 · Fiscal year end 1231
Latest reported period: Latest published period
Operating Income
$-485,883
Net Income
$-485,883
Eps Basic
-0.03
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-485,883 | - | - |
| Net Income | $-485,883 | - | - |
| Eps Basic | -0.03 | - | - |
| Eps Diluted | -0.03 | - | - |
| Total Assets | $1.5M | - | - |
| Total Liabilities | $5.4M | - | - |
| Shareholders Equity | $-3.9M | - | - |
| Operating Cash Flow | $-374,176 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | Accustem Sciences Inc. | 2026-05-15 | 0001493152-26-023742 |
| 10-K | Accustem Sciences Inc. | 2026-04-14 | 0001493152-26-016559 |
| 10-Q | Accustem Sciences Inc. | 2025-11-12 | 0001493152-25-021919 |
| 10-Q | Accustem Sciences Inc. | 2025-08-14 | 0001641172-25-023786 |